PEAK6 Investments »

Kalvista Pharmaceuticals shares owned by PEAK6 Investments

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by PEAK6 Investments from 13F filings

Historical chart of PEAK6 Investments investment in Kalvista Pharmaceuticals

Apr 2024May 2024Jun 2024Jul 2024Aug 2024Sep 2024Oct 2024174k175k176k177k178k14.999k14.9995k15k15.0005k15.001k
Value ($)Share countHistorical KALV position of PEAK6 Investments Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by PEAK6 Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by PEAK6 Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $174k 15k 11.58
2024-06-30 $177k 15k 11.78
2024-03-31 $178k 15k 11.86

More positions owned by PEAK6 Investments

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Broadcom Call Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Advanced Micro Devices Call Option (AMD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon Call Option (AMZN)
Microstrategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for PEAK6 Investments

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Suvretta Capital Management
Tang Capital Management
Frazier Life Sciences Management
Vestal Point Capital
Capital World Investors
BlackRock
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Boxer Capital Management
State Street Corporation
Octagon Capital Advisors
Woodline Partners
Emerald Advisers
Geode Capital Management

View all funds holding Kalvista Pharmaceuticals